Director of Corporate Communications, Freenome
$197.2-304k
2-3 days a week in office (Brisbane, CA)
Biological analysis platform for cancer
Open for applications
Biological analysis platform for cancer
501-1000 employees
Open for applications
$197.2-304k
2-3 days a week in office (Brisbane, CA)
501-1000 employees
Company mission
To reinvent disease management through early detection and precision intervention.
Role
Who you are
- Bachelor's degree in communications, public relations, journalism, or a related field (advanced degree preferred)
- Minimum of 10 years of experience in corporate communications, public relations, or related roles, preferably in the biotechnology, healthcare, or life sciences industry
- Proven track record of developing and executing successful communications strategies that drive brand awareness, media coverage, and stakeholder engagement
- Strong writing, editing, and storytelling skills, with the ability to craft compelling messages for diverse audiences and channels
- Excellent leadership, strategic thinking, and project management abilities, with experience leading cross-functional teams and managing budgets
- Demonstrated experience in media relations, crisis communications, executive communications, and internal communications
- Proficiency in digital and social media platforms, analytics tools, and content management systems
What the job involves
- Freenome is seeking a dynamic and strategic Director of Corporate Communications to lead our communications efforts and enhance Freenome's visibility, reputation, and stakeholder engagement
- Reporting directly to the Chief People Officer in the interim until the Chief Commercial Officer joins, you will play a critical role in shaping and driving our external and internal communications strategies to support our business objectives and mission
- Develop and execute comprehensive corporate communications strategies aligned with Freenome's vision, goals, and brand identity
- Lead the development of messaging, positioning, and narratives to effectively communicate Freenome's value proposition, achievements, and industry leadership
- Build and maintain strong relationships with media outlets, journalists, and industry influencers to secure positive coverage and media opportunities
- Develop and distribute press releases, media pitches, and other communications materials to enhance Freenome's visibility and thought leadership
- Partner with executive leadership to craft compelling communications for internal and external audiences, including speeches, presentations, and talking points
- Provide strategic counsel and support to executives on media interviews, public appearances, and crisis communications
- Develop and implement internal communications strategies to engage and inform employees, fostering a culture of transparency, collaboration, and alignment
- Lead the development of employee communications, newsletters, intranet content, and town hall meetings to enhance employee engagement and morale
- Oversee Freenome's digital and social media presence, including content development, social media campaigns, and analytics
- Monitor industry trends, online conversations, and competitor activity to inform digital and social media strategies and tactics
- Ensure consistency and alignment in corporate branding, messaging, and visual identity across all communications channels and materials
- Proactively manage and protect Freenome's reputation through effective crisis communications planning and response strategies
Our take
Freenome is a biotechnology company offering a biological analysis platform that uses molecular biology and machine learning to detect cancer with a routine blood draw. The platform trains on thousands of cancer-positive blood samples to recognise disease-associated patterns and help detect early-stage cancer, allowing clinicians to optimise treatments.
The company specialises in advanced computational biology, using machine learning to detect patterns among billions of circulating cell-free biomarkers. Freenome continues to focus on the development of its colorectal cancer test, potentially helping the 45 million people not currently up-to-date on colorectal cancer screening guidelines in the United States.
Following its 2022 funding round, the company surpassed the $1 billion funding mark. Freenome is set to accelerate the development of its platform, testing for additional cancers and furthering its blood test detection technology. It's also forming partnerships for R&D purposes, joining forces with health firms such as Geisinger to provide real world data that could help it detect multiple cancers.
Steph
Company Specialist at Welcome to the Jungle
Insights
Company
Funding (last 2 of 7 rounds)
Feb 2024
$254m
LATE VC
Dec 2021
$300m
SERIES D
Total funding: $1.1bn
Company benefits
- Pre-IPO equity
- Flexible PTO (exempt) and generous PTO (non-exempt)
- Comprehensive health coverage, including medical, dental, and vision
- Wellness and mental health resources, including Employee Assistance Programs (EAPs), Paid maternity and paternity leave
- 401(k) plan
- Plus, a variety of other perks, including pre-tax commuter benefits, two paid volunteer days per year, pet insurance, and additional discounts
Company HQ
The East Side, South San Francisco, CA
Articles
Leadership
Riley Ennis
(CPO)Studied at Yale, Johns Hopkins and Dartmouth. Was a Thiel Fellow and co-founded Immudicon and Oncolinx.
Salary benchmarks
We don't have enough data yet to provide salary benchmarks for this role.
Submit your salary to help other candidates with crowdsourced salary estimates.
Share this job
View 3 more jobs at Freenome